Trial intelligence / Profile preview

Pegasys sequential therapy following entecavir vs Pegasys monotherapy in HBeAg-positive chronic hepatitis B

KCT0000042Phase 3Recruiting

Sponsor
Roche
Start
Jun 2010
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in Chronic Hepatitis B (CHB) comparing Pegasys monotherapy with Sequential entecavir then Pegasys (2 arms). Started Jun 2010; status: recruiting.

02

Drugs

interferon alfaentecavir
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on KCT0000042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call